Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
BMC Complement Altern Med ; 19(1): 21, 2019 Jan 17.
Article in English | MEDLINE | ID: mdl-30654773

ABSTRACT

BACKGROUND: Peppermint oil (PO) has intrinsic properties that may benefit patients with irritable bowel syndrome (IBS) symptoms. The study objective was to determine the effect of peppermint oil in the treatment of the IBS. METHODS: We systematically searched MEDLINE (PubMed), Cochrane Central Register of Controlled Trials (Cochrane CENTRAL), ClinicalTrials.gov, EMBASE (Ovid), and Web of Science for randomized controlled trials (RCTs) of PO for IBS. We appraised the eligible studies by the Cochrane risk of bias tool. We performed random-effects meta-analysis on primary outcomes including global improvement in IBS symptoms and abdominal pain. A PRISMA-compliant study protocol is registered in PROSPERO Register [2016, CRD42016050917]. RESULTS: Twelve randomized trials with 835 patients were included. For global symptom improvement, the risk ratio (RR) from seven RCTs for the effect of PO (n = 253) versus placebo (n = 254) on global symptoms was 2.39 [95% confidence interval (CI): 1.93, 2.97], I2 = 0%, z = 7.93 (p < 0.00001). Regarding abdominal pain, the RR from six RCTs for the effect of PO (n = 278) versus placebo (n = 278) was 1.78 [95% CI: 1.43, 2.20], I2 = 0%, z = 5.23 (p < 0.00001). Overall, there were no differences in the reported adverse effects: PO (32 events, 344 total, 9.3%) versus placebo (20 events, 327 total, 6.1%) for eight RCTs; RR 1.40 [95% CI: 0.87, 2.26] I2 = 0%, z = 1.39 (p = 0.16). The number needed to treat with PO to prevent one patient from having persistent symptoms was three for global symptoms and four for abdominal pain. CONCLUSIONS: In the most comprehensive meta-analysis to date, PO was shown to be a safe and effective therapy for pain and global symptoms in adults with IBS.


Subject(s)
Irritable Bowel Syndrome/drug therapy , Plant Oils/therapeutic use , Humans , Mentha piperita , Treatment Outcome
2.
J Econ Entomol ; 91(4): 841-6, 1998 Aug.
Article in English | MEDLINE | ID: mdl-9725032

ABSTRACT

The plant-produced indole alkaloid tryptamine is one of a large array of neuroactive substances that may affect insect behavior, development, and physiology. We tested the role of tryptamine on insect reproduction using the fruit fly, Drosophila melanogaster (Meigen), as a model system. Measurements were made of reproductive success, oviposition rate, and preadult survival of insects on artificial diets containing tryptamine, its precursor tryptophan, as well as glycine and serotonin (5-hydroxytryptamine). Drosophila reproduction was reduced to 15% of controls when adult insects mated and the young were allowed to develop on medium containing 75 mM tryptamine. Tryptamine-induced depression in reproductive success was due to decreased oviposition rate and preadult survival. Serotonin, but not tryptophan or glycine, also reduced oviposition rate. Preference tests indicated that tryptamine may act as an antiattractant or antifeedant in this species. The accumulation of the indole alkaloid tryptamine in plants may provide a mechanism for reducing insect reproduction, which is potentially useful in protecting crop plants.


Subject(s)
Drosophila melanogaster/physiology , Tryptamines/pharmacology , Animals , Drosophila melanogaster/drug effects , Female , Male , Oviposition/drug effects , Reproduction/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...